Steven Cohen's ELV Position Overview
Steven Cohen (via Point72 Asset Management, L.P.) currently holds 59,341 shares of Elevance Health, Inc. (ELV) worth $17.37 M, representing 0.02% of the portfolio. First purchased in 2016-Q1, this long-term strategic position has been held for 31 quarters.
Based on 13F filings, Steven Cohen has maintained a strategic position in ELV, demonstrating sustained confidence in this investment. Largest addition occurred in Q1 2019, adding 557,470 shares. Largest reduction occurred in Q2 2019, reducing 602,597 shares.
Analysis based on 13F filings available since 2013 Q2
Steven Cohen's Elevance Health (ELV) Holding Value Over Time
Track share changes against reported price movement
Quarterly Elevance Health (ELV) Trades by Steven Cohen
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q1 2026 | +59,341 | New Buy | 59,341 | $292.75 |
| Q2 2025 | -217,598 | Sold Out | 0 | $0.00 |
| Q1 2025 | +217,598 | New Buy | 217,598 | $434.96 |
| Q3 2024 | -242,881 | Sold Out | 0 | $0.00 |
| Q2 2024 | -60,574 | Reduce 19.96% | 242,881 | $541.86 |
| Q1 2024 | +239,147 | Add 371.88% | 303,455 | $518.54 |
| Q4 2023 | +62,104 | Add 2817.79% | 64,308 | $471.56 |
| Q3 2023 | -6,543 | Reduce 74.80% | 2,204 | $435.42 |
| Q2 2023 | -287,021 | Reduce 97.04% | 8,747 | $444.29 |
| Q1 2023 | +232,943 | Add 370.78% | 295,768 | $459.81 |
| Q4 2022 | +62,825 | New Buy | 62,825 | $512.97 |
| Q2 2022 | -61,151 | Sold Out | 0 | $0.00 |
| Q1 2022 | +17,451 | Add 39.93% | 61,151 | $491.23 |
| Q4 2021 | -104,400 | Reduce 70.49% | 43,700 | $463.55 |
| Q3 2021 | +78,840 | Add 113.83% | 148,100 | $372.80 |
| Q2 2021 | +34,760 | Add 100.75% | 69,260 | $381.79 |
| Q1 2021 | -237,743 | Reduce 87.33% | 34,500 | $358.96 |
| Q4 2020 | +217,943 | Add 401.37% | 272,243 | $321.09 |
| Q3 2020 | +54,300 | New Buy | 54,300 | $268.58 |
| Q2 2019 | -602,597 | Sold Out | 0 | $0.00 |
| Q1 2019 | +557,470 | Add 1235.34% | 602,597 | $286.98 |
| Q4 2018 | -36,263 | Reduce 44.55% | 45,127 | $262.64 |
| Q3 2018 | -220,263 | Reduce 73.02% | 81,390 | $274.05 |
| Q2 2018 | +166,553 | Add 123.28% | 301,653 | $238.03 |
| Q1 2018 | -27,600 | Reduce 16.96% | 135,100 | $219.70 |
| Q4 2017 | +162,700 | New Buy | 162,700 | $225.01 |
| Q1 2017 | -5,000 | Sold Out | 0 | $0.00 |
| Q4 2016 | -56,000 | Reduce 91.80% | 5,000 | $143.80 |
| Q3 2016 | +61,000 | New Buy | 61,000 | $125.31 |
| Q2 2016 | -167,800 | Sold Out | 0 | $0.00 |
| Q1 2016 | +167,800 | New Buy | 167,800 | $138.99 |
Steven Cohen's Elevance Health Investment FAQs
Steven Cohen first purchased Elevance Health, Inc. (ELV) in Q1 2016, acquiring 167,800 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Steven Cohen has held Elevance Health, Inc. (ELV) for 31 quarters since Q1 2016.
Steven Cohen's largest addition to Elevance Health, Inc. (ELV) was in Q1 2019, adding 602,597 shares worth $172.93 M.
According to the latest 13F filing for Q1 2026, Steven Cohen's firm, Point72 Asset Management, L.P., owns 59,341 shares of Elevance Health, Inc. (ELV), valued at approximately $17.37 M.
As of the Q1 2026 filing, Elevance Health, Inc. (ELV) represents approximately 0.02% of Steven Cohen's publicly disclosed stock portfolio, making it one of their key holdings.
Steven Cohen's peak holding in Elevance Health, Inc. (ELV) was 602,597 shares, as reported at the end of Q1 2019.